Previous 10 | Next 10 |
Scopus BioPharma (SCPS) has priced its public offering of 1M common shares at $9.00/share, for proceeds of $9M.Underwriters' over-allotment is an additional 150K shares. Proceeds will be used for further development of company's lead drug candidate, including in combination with checkpoint in...
Scopus BioPharma Announces Pricing of $9 Million Follow-On Public Offering PR Newswire NEW YORK , Jan. 26, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the pricing of a $9 million follow-on public offering. The offerin...
Scopus BioPharma ([[SCPS]] +8.3%) completed clinical lot manufacturing fulfilling the requirements for the planned Phase 1 clinical trial for non-Hodgkin's lymphoma enabling finalization of the investigational new drug package for submission to the U.S. FDA.The company's lead drug candid...
Scopus BioPharma Announces Completion of Clinical Lot Manufacture Manufactured Lot Fulfills Requirements for Planned Phase 1 Clinical Trial Key milestone to enable finalization of IND package for submission to FDA PR Newswire NEW YORK , Jan. 19, 2021 /PRN...
Gainers: Bionano Genomics (BNGO) +90%, Ocugen OCGN +72%, ViewRay VRAY +26%, Pandion Therapeutics PAND +25%, EyePoint Pharmaceuticals EYPT +21%.Losers: Calithera Biosciences CALA -41%, Acorda Therapeutics (ACOR) -16%, Sigilon The...
Scopus BioPharma Announces Appointment of Additional Directors PR Newswire NEW YORK , Dec. 29, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the appointment of additional members to its Board of Directors. Scopus is a bi...
Gainers: [[ACY]] +39.4%. [[MREO]] +5.0%. [[SOAC]] +4.2%. [[GTHX]] +4.0%. [[STPK]] +3.4%.Losers: [[AIRT]] -23.1%. [[SCPS]] -9.4%. [[TRITW]] -6.8%. [[ID]] -6.0%. [[VET]] -4.9%. For further details see: ACY, MREO, AIRT and ID among after-hours movers
Gainers: Jaguar Health (JAGX) +191%.Ocugen (OCGN) +177%.Acasti Pharma (ACST) +88%.Scopus BioPharma (SCPS) +50%.Foresight Autonomous Holdings (FRSX) +35%.Onconova Therapeutics (ONTX) +32%.Evogene (EVGN) +31%.Energous Corporation (WATT) +29%.VivoPower International (VVPR) +26%.Phoenix New Media...
Gainers: Ocugen (OCGN) +263%, Jaguar Health (JAGX) +108%, Acasti Pharma (ACST) +61%, Scopus BioPharma (SCPS) +43%, Ekso Bionics Holdings (EKSO) +21%.Losers: Cellectar Biosciences (CLRB) -31%, CRH Medical (CRHM) -23%, CNS Pharmaceuticals (...
Lizhi (LIZI) +29%.Ekso Bionics Holdings (EKSO) +25%.AgEagle Aerial Systems (UAVS) +22%.ENGlobal Corporation (ENG) +23%.Supernus Pharmaceuticals (SUPN) +23%.Scopus BioPharma (SCPS) +21%.Mogo (MOGO) +18%.Magnite (MGNI) +18%.Kopin Corporation (KOPN) +18%.Magna International (MGA) +18%.InMed Phar...
News, Short Squeeze, Breakout and More Instantly...
Scopus BioPharma Inc. Company Name:
SCPS Stock Symbol:
NASDAQ Market:
Scopus BioPharma Inc. Website:
DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma Data Suggests Benefits of Combinations of DUET-102 with Other T-Cell Based Immunotherapies, such as CAR-Ts NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Scopus B...
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (OTCQB: “SCPS ”) , a biotechnology company developing transformational therapeutics for serious diseases with significant unmet medical need, and its subsidiary, Duet BioTherapeutics Inc., which is...
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) , a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, and its pure-play immuno-oncology subsidiary, Duet Bi...